Press Release: Nipro Diagnostics, Inc. announces FDA clearance of its newest blood glucose monitoring systems

Nipro Diagnostics, Inc. announces FDA clearance of its newest blood glucose monitoring systems, True Metrix and True Metrix Pro, and expansion of manufacturing in the USA

FORT LAUDERDALE, Fla. – Nipro Diagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared its True Metrix Self-Monitoring blood glucose system and the True Metrix Pro Professional Monitoring blood glucose system.

Nipro Diagnostics

News Well, Press Release, Regulatory/Clearance, 510(k), Diabetes, Food & Drug Administration (FDA)

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tCgeO0